<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8900963</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1466</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Neurobiol.</journal-id>
<journal-title-group>
<journal-title>Molecular neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-7648</issn>
<issn pub-type="epub">1559-1182</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28502042</article-id>
<article-id pub-id-type="pmc">6370010</article-id>
<article-id pub-id-type="doi">10.1007/s12035-017-0525-3</article-id>
<article-id pub-id-type="manuscript">NIHMS1010027</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shah</surname>
<given-names>Kavita</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0451-1305</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rossie</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Chemistry and Purdue University Center of Cancer Research, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, USA</aff>
<aff id="A2"><label>2</label>Department of Biochemistry, Purdue University, West Lafayette, IN 47907, USA</aff>
<author-notes>
<corresp id="CR1">Kavita Shah, <email>shah23@purdue.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>55</volume>
<issue>4</issue>
<fpage>3426</fpage>
<lpage>3438</lpage>
<!--elocation-id from pubmed: 10.1007/s12035-017-0525-3-->
<abstract id="ABS1">
<p id="P1">Cdk5 kinase, a cyclin-dependent kinase family member, is a key regulator of cytoskeletal remodeling in the brain. Cdk5 is essential for brain development during embryogenesis. After birth, it is essential for numerous neuronal processes such as learning and memory formation, drug addiction, pain signaling, and long-term behavior changes, all of which rely on rapid alterations in the cytoskeleton. Cdk5 activity is deregulated in various brain disorders including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and ischemic stroke, resulting in profound remodeling of the neuronal cytoskeleton, loss of synapses, and ultimately neurodegeneration. This review focuses on the “good and bad” Cdk5 in the brain and its pleiotropic contribution in regulating neuronal actin cytoskeletal remodeling. A vast majority of physiological and pathological Cdk5 substrates are associated with the actin cytoskeleton. Thus, our special emphasis is on the numerous Cdk5 substrates identified in the past two decades such as ephexin1, p27, Mst3, CaMKv, kalirin-7, RasGRF2, Pak1, WAVE1, neurabin-1, TrkB, 5-HT6R, talin, drebrin, synapsin I, synapsin III, CRMP1, GKAP, SPAR, PSD-95, and LRRK2. These substrates have unraveled the molecular mechanisms by which Cdk5 plays divergent roles in regulating neuronal actin cytoskeletal dynamics both in healthy and diseased states.</p>
</abstract>
<kwd-group>
<kwd>Cdk5</kwd>
<kwd>p25</kwd>
<kwd>p35</kwd>
<kwd>β-Amyloid</kwd>
<kwd>Neuronal cytoskeleton</kwd>
<kwd>Actin</kwd>
<kwd>Microtubules</kwd>
<kwd>Remodeling</kwd>
<kwd>Cdk</kwd>
<kwd>Cyclins</kwd>
<kwd>Neurodegeneration</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>Dendritic spines</kwd>
<kwd>Neurotransmitters</kwd>
<kwd>Synaptic plasticity</kwd>
<kwd>Learning and memory</kwd>
<kwd>Neuronal migration</kwd>
<kwd>Axonal growth</kwd>
<kwd>Neurotransmitters</kwd>
<kwd>Synaptogenesis</kwd>
<kwd>Drug addiction</kwd>
<kwd>Ephexin1</kwd>
<kwd>p25</kwd>
<kwd>Mst3</kwd>
<kwd>CaMKv</kwd>
<kwd>Kalirin-7</kwd>
<kwd>RasGRF2</kwd>
<kwd>Pak1</kwd>
<kwd>WAVE1</kwd>
<kwd>Neurabin-1</kwd>
<kwd>TrkB</kwd>
<kwd>5-HT6R</kwd>
<kwd>Talin</kwd>
<kwd>Drebrin</kwd>
<kwd>Synapsin I</kwd>
<kwd>Synapsin III</kwd>
<kwd>CRMP1</kwd>
<kwd>GKAP</kwd>
<kwd>SPAR</kwd>
<kwd>PSD-95</kwd>
<kwd>LRRK2</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>